Understanding staging challenges in pericystic lung cancer lesions скачать в хорошем качестве

Understanding staging challenges in pericystic lung cancer lesions

Matthew Evison, MD, MRCP, Manchester University Hospital NHS Foundation Trust, Manchester, UK, discusses the challenges of understanding and managing pericystic lesions in lung cancer, which account for 1% to 4% of lung cancers. Further research is needed to develop a framework for staging these lesions, and while solid nodules and sub-solid nodules have established frameworks for staging, pericystic lesions lack a clear framework, leading to potential under or over staging and treatment. This interview took place at the 2026 British Thoracic Oncology Group (BTOG) congress in Edinburgh, UK. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.